Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Mouth Ulcers Drugs Market by Type (Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial), By Application (Aphthous Stomatitis, Oral Lichen Planus, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Mouth Ulcers Drugs Market by Type (Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial), By Application (Aphthous Stomatitis, Oral Lichen Planus, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131942 3300 Pharma & Healthcare 377 233 Pages 4.6 (31)
                                          

The global mouth ulcers drugs market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of mouth ulcers and the rising awareness about its treatment. Mouth ulcers are caused by various factors such as stress, hormonal changes, nutritional deficiencies, and infections. Mouth ulcers are also associated with other diseases such as HIV/AIDS and cancer. The most common type of mouth ulcer is aphthous stomatitis which affects more than 50% of people in their lifetime. Oral lichen planus is another type that affects more than 10% people in their lifetime and it has been found that it can be caused by an autoimmune disorder or a viral infection like herpes simplex virus-1 (HSV-1). Corticosteroids are used for treating aphthous stomatitis which causes inflammation in the oral cavity due to an allergic reaction or irritation from food particles or bacteria; they reduce swelling and redness around the affected area while providing relief from pain and discomfort associated with this condition. Anesthetics are used for treating oral lichen planus which causes lesions on mucosal surfaces; they provide relief from pain by numbing nerve endings while reducing inflammation around these lesions so that healing can take place without any discomfort or pain felt by patients suffering from this condition. Antihistamines are used for treating allergic reactions like hay fever; they reduce symptoms like sneezing, runny nose, watery eyes, itching eyes/nose/throat etc, while providing relief from itchiness due to allergies caused due to pollen grains entering through nasal passages into respiratory tract where histamine is released causing these symptoms.

Some Of The Growth Factors Of This Market:

  1. The mouth ulcers drugs market is driven by the increasing prevalence of oral diseases and the growing awareness about oral health among people globally.
  2. Oral diseases are caused due to various factors such as poor oral hygiene, smoking, alcohol consumption, and stress which leads to inflammation in the mouth lining or mucosa which causes sores on the tongue or inside cheeks or lips called as mouth ulcers. Mouth ulcers can be painful and may lead to difficulty in eating food and speaking properly which can affect one's quality of life significantly leading them towards depression and anxiety disorders too. Hence there is an increasing demand for treatment options for these conditions that are available over-the-counter without prescription from a doctor or dentist such as pain relief medicines like ibuprofen (Advil) or acetaminophen (Tylenol).
  3. Mouth ulcer drugs are also used for treating other conditions such as aphthous stomatitis (canker sores), cold sores, fever blisters, herpes simplex virus type 1 infection (cold sore), herpes simplex virus type 2 infection (genital herpes), lichen planus erythematosus (a skin condition that causes itchy red patches on skin) etc, hence driving their demand globally too with an increase in awareness about these conditions among people worldwide leading them towards seeking treatment options for these conditions without visiting a doctor's clinic first before they get worse with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever.

Industry Growth Insights published a new data on “Mouth Ulcers Drugs Market”. The research report is titled “Mouth Ulcers Drugs Market research by Types (Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial), By Applications (Aphthous Stomatitis, Oral Lichen Planus, Others), By Players/Companies 3M, BLISTEX, Bristol-Myers Squibb Company, Church & Dwight, The Colgate-Palmolive Company, ECR Pharmaceuticals, GlaxoSmithKline, Pfizer, Taro Pharmaceutical Industries”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Mouth Ulcers Drugs Market Research Report

By Type

Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial

By Application

Aphthous Stomatitis, Oral Lichen Planus, Others

By Companies

3M, BLISTEX, Bristol-Myers Squibb Company, Church & Dwight, The Colgate-Palmolive Company, ECR Pharmaceuticals, GlaxoSmithKline, Pfizer, Taro Pharmaceutical Industries

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Mouth Ulcers Drugs Industry Outlook


Global Mouth Ulcers Drugs Market Report Segments:

The global Mouth Ulcers Drugs market is segmented on the basis of:

Types

Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Aphthous Stomatitis, Oral Lichen Planus, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. 3M
  2. BLISTEX
  3. Bristol-Myers Squibb Company
  4. Church & Dwight
  5. The Colgate-Palmolive Company
  6. ECR Pharmaceuticals
  7. GlaxoSmithKline
  8. Pfizer
  9. Taro Pharmaceutical Industries

Global Mouth Ulcers Drugs Market Overview


Highlights of The Mouth Ulcers Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Corticosteroid
    2. Anesthetic
    3. Analgesic
    4. Antihistamine
    5. Antimicrobial
  1. By Application:

    1. Aphthous Stomatitis
    2. Oral Lichen Planus
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Mouth Ulcers Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Mouth Ulcers Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Mouth Ulcers Drugs Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Mouth Ulcers Drugs Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Mouth Ulcers Drugs Market - Supply Chain
   4.5. Global Mouth Ulcers Drugs Market Forecast
      4.5.1. Mouth Ulcers Drugs Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Mouth Ulcers Drugs Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Mouth Ulcers Drugs Market Absolute $ Opportunity

5. Global Mouth Ulcers Drugs Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Type
      5.3.1. Corticosteroid
      5.3.2. Anesthetic
      5.3.3. Analgesic
      5.3.4. Antihistamine
      5.3.5. Antimicrobial
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Mouth Ulcers Drugs Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Application
      6.3.1. Aphthous Stomatitis
      6.3.2. Oral Lichen Planus
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Mouth Ulcers Drugs Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Mouth Ulcers Drugs Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Mouth Ulcers Drugs Demand Share Forecast, 2019-2029

9. North America Mouth Ulcers Drugs Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Mouth Ulcers Drugs Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Mouth Ulcers Drugs Market Size and Volume Forecast by Application
      9.4.1. Aphthous Stomatitis
      9.4.2. Oral Lichen Planus
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Mouth Ulcers Drugs Market Size and Volume Forecast by Type
      9.7.1. Corticosteroid
      9.7.2. Anesthetic
      9.7.3. Analgesic
      9.7.4. Antihistamine
      9.7.5. Antimicrobial
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Mouth Ulcers Drugs Demand Share Forecast, 2019-2029

10. Latin America Mouth Ulcers Drugs Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Mouth Ulcers Drugs Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Mouth Ulcers Drugs Market Size and Volume Forecast by Application
      10.4.1. Aphthous Stomatitis
      10.4.2. Oral Lichen Planus
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Mouth Ulcers Drugs Market Size and Volume Forecast by Type
      10.7.1. Corticosteroid
      10.7.2. Anesthetic
      10.7.3. Analgesic
      10.7.4. Antihistamine
      10.7.5. Antimicrobial
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Mouth Ulcers Drugs Demand Share Forecast, 2019-2029

11. Europe Mouth Ulcers Drugs Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Mouth Ulcers Drugs Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Mouth Ulcers Drugs Market Size and Volume Forecast by Application
      11.4.1. Aphthous Stomatitis
      11.4.2. Oral Lichen Planus
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Mouth Ulcers Drugs Market Size and Volume Forecast by Type
      11.7.1. Corticosteroid
      11.7.2. Anesthetic
      11.7.3. Analgesic
      11.7.4. Antihistamine
      11.7.5. Antimicrobial
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9.Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Mouth Ulcers Drugs Demand Share, 2019-2029

12. Asia Pacific Mouth Ulcers Drugs Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Mouth Ulcers Drugs Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Mouth Ulcers Drugs Market Size and Volume Forecast by Application
      12.4.1. Aphthous Stomatitis
      12.4.2. Oral Lichen Planus
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Mouth Ulcers Drugs Market Size and Volume Forecast by Type
      12.7.1. Corticosteroid
      12.7.2. Anesthetic
      12.7.3. Analgesic
      12.7.4. Antihistamine
      12.7.5. Antimicrobial
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Mouth Ulcers Drugs Demand Share, 2019-2029

13. Middle East & Africa Mouth Ulcers Drugs Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Mouth Ulcers Drugs Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Mouth Ulcers Drugs Market Size and Volume Forecast by Application
      13.4.1. Aphthous Stomatitis
      13.4.2. Oral Lichen Planus
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Mouth Ulcers Drugs Market Size and Volume Forecast by Type
      13.7.1. Corticosteroid
      13.7.2. Anesthetic
      13.7.3. Analgesic
      13.7.4. Antihistamine
      13.7.5. Antimicrobial
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Mouth Ulcers Drugs Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Mouth Ulcers Drugs Market: Market Share Analysis
   14.2. Mouth Ulcers Drugs Distributors and Customers
   14.3. Mouth Ulcers Drugs Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. 3M
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. BLISTEX
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Bristol-Myers Squibb Company
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Church & Dwight
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. The Colgate-Palmolive Company
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. ECR Pharmaceuticals
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. GlaxoSmithKline
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Pfizer
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Taro Pharmaceutical Industries
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us